A CYP21A2 gene mutation in patients with congenital adrenal hyperplasia. Molecular genetics report from Saudi Arabia

Saudi Med J. 2015 Jan;36(1):113-6. doi: 10.15537/smj.2015.1.9697.

Abstract

Objectives: The aim of this study is to determine congenital adrenal hyperplasia (CAH) with the pattern of CYP21A2 gene-mutations in Saudi children.

Methods: Between January 2011 and March 2014 at King Fahad Military Complex, Dhahran, Saudi Arabia, we thoroughly examined 11 patients with CAH and 2 asymptomatic individuals with a history of affected siblings. Additionally, we sequenced the full coding regions of the CYP21A2 gene and screened the gene for deletion(s)/duplication(s) using the multiplex ligation-dependent probe amplification (MLPA) technique.

Results: Nine patients had classic CAH and presented with ambiguous genitalia and/or salt losing crisis. Two patients had the non-classic form of CAH and presented with precocious puberty. The remaining 2 subjects were asymptomatic. Screening the CYP21A2 gene, we detected p.Gln318X mutation in 4 patients, c.290 -13 C>G (IVS2-13C>G) in another 4, and a common deletion, involving exons 6 and 8 in 3 patients.

Conclusion: Our strategy of Sanger sequencing followed by MLPA was very successful in detecting CYP21A2 mutations in all patients with CAH.

MeSH terms

  • Adrenal Hyperplasia, Congenital / genetics*
  • Child
  • Child, Preschool
  • Female
  • Gene Deletion*
  • Gene Duplication*
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Saudi Arabia
  • Steroid 21-Hydroxylase / genetics*

Substances

  • CYP21A2 protein, human
  • Steroid 21-Hydroxylase